Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
succinate dehydrogenase complex flavoprotein subunit A | 0.517 | 0.731 | 2.6E-10 |
|
group | 0.700 | strong | 1.000 | 4 | 0 | 2004 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2011 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2011 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 1.000 | definitive | 0.951 | 2 | 0 | 1995 | 2020 | ||||||||
|
parathyroid hormone 1 receptor | 0.544 | 0.731 | 0.57 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2008 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2015 | ||||||||
|
GATA binding protein 2 | 0.496 | 0.654 | 0.98 |
|
group | 0.800 | None | 0.976 | 1 | 0 | 2002 | 2019 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
group | 0.800 | definitive | 0.954 | 1 | 0 | 2003 | 2020 | ||||||||
|
succinate dehydrogenase complex iron sulfur subunit B | 0.474 | 0.846 | 2.4E-04 |
|
group | 0.800 | None | 0.971 | 1 | 0 | 1982 | 2019 | ||||||||
|
succinate dehydrogenase complex subunit C | 0.517 | 0.846 | 2.0E-04 |
|
group | 0.800 | strong | 0.973 | 1 | 0 | 2000 | 2019 | ||||||||
|
TNF receptor superfamily member 1B | 0.425 | 0.885 | 0.50 |
|
group | 0.510 | None | 1.000 | 1 | 0 | 2015 | 2016 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
group | 0.700 | None | 1.000 | 1 | 0 | 1983 | 2019 | ||||||||
|
cytochrome b-245 chaperone 1 | 0.736 | 0.462 | 6.0E-04 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
CD28 molecule | 0.436 | 0.885 | 0.36 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1994 | 2015 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1994 | 2018 | ||||||||
|
interleukin 2 receptor subunit gamma | 0.535 | 0.769 | 0.99 |
|
group | 0.800 | strong | 0.965 | 0 | 0 | 1989 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 1976 | 2015 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 4 | 0.546 | 0.654 | 2.4E-10 |
|
phenotype | 0.900 | None | 1.000 | 3 | 0 | 1989 | 2017 | ||||||||
|
SON DNA binding protein | 0.565 | 0.769 | 1.00 |
|
phenotype | 0.710 | None | 1.000 | 3 | 0 | 2015 | 2019 | ||||||||
|
thyroid stimulating hormone subunit beta | 0.670 | 0.538 | 8.4E-03 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2003 | 2012 | ||||||||
|
ubiquitin specific peptidase 9 Y-linked | 0.743 | 0.269 | 5.7E-05 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1999 | 2012 | ||||||||
|
ubiquitin specific peptidase 9 Y-linked | 0.743 | 0.269 | 5.7E-05 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1999 | 2012 | ||||||||
|
DEAD-box helicase 3 Y-linked | 0.722 | 0.269 | 0.96 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2000 | 2012 | ||||||||
|
DEAD-box helicase 3 Y-linked | 0.722 | 0.269 | 0.96 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2000 | 2012 | ||||||||
|
cadherin 11 | 0.512 | 0.808 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2017 | 2018 |